Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11007184
Cancer treatments using combinations of type 2 MEK and ERK inhibitors
granted -
US 11007183
Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors
granted -
US 11007201
Corticotropin releasing factor receptor antagonists
granted -
US 11007186
Methods of treating RBP4 related diseases with triazolopyridines
granted -
US 11007193
2,4-pyrimidinediamine compounds and their uses
granted -
US 11008564
Processing engineered FMDV P1 polypeptide using an alternative TEV protease
granted -
US 11008381
Antibodies to oxidized phospholipids
granted -
US 11007261
Compositions and methods of vaccination against dengue virus in children and young adults
granted -
US 11008304
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 11007249
Compositions comprising pregnancy specific glycoproteins and methods of use thereof
granted -
US 11007171
Treatment and prevention of joint disorders
granted -
US 11008314
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
granted -
US 11007385
Use of cellular extracts for skin rejuvenation
granted -
US 11007217
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
granted -
US 11006626
Compounds for protection of cells
granted -
US 11000513
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 11000481
Composite preparation of mosapride and rabeprazole
granted -
US 11001641
Monoclonal antibody therapy for pancreas cancer
granted -
US 11001594
Heterocyclic modulators of HIF activity for treatment of disease
granted -
US 11001551
Controlled release pharmaceutical formulations
granted -
US 11001820
Delivery of therapeutic agents by a collagen binding protein
granted -
US 11000579
Recombinant Eimeria maxima protein delivered as nanoparticles
granted -
US 11001564
Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
granted -
US 11001892
Methods of diagnosing endometriosis
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.